Nutcracker esophagus medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Formatting)
 
Line 2: Line 2:
{{Nutcracker esophagus}}
{{Nutcracker esophagus}}
{{CMG}}
{{CMG}}
==Overview==
==Medical Therapy==
==Medical Therapy==
Nutcracker esophagus is a benign, non-progressive condition, meaning that it is not associated with significant complications.  Patients are usually reassured by their physicians that the disease is not associated with worsening.  However, the symptoms of chest pain and dysphagia may be severe enough to require treatment with medications, and, rarely, surgery.
Nutcracker esophagus is a benign, non-progressive condition, meaning that it is not associated with significant complications.  Patients are usually reassured by their physicians that the disease is not associated with worsening.  However, the symptoms of chest pain and dysphagia may be severe enough to require treatment with medications, and, rarely, surgery.
Line 15: Line 19:
==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Disease]]
[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]

Latest revision as of 18:16, 8 July 2016

Nutcracker esophagus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nutcracker esophagus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nutcracker esophagus medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nutcracker esophagus medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nutcracker esophagus medical therapy

CDC on Nutcracker esophagus medical therapy

Nutcracker esophagus medical therapy in the news

Blogs on Nutcracker esophagus medical therapy

Directions to Hospitals Treating Nutcracker esophagus

Risk calculators and risk factors for Nutcracker esophagus medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medical Therapy

Nutcracker esophagus is a benign, non-progressive condition, meaning that it is not associated with significant complications. Patients are usually reassured by their physicians that the disease is not associated with worsening. However, the symptoms of chest pain and dysphagia may be severe enough to require treatment with medications, and, rarely, surgery.

The first step in treatment of nutcracker esophagus is the reduction of risk factors. While weight reduction may be useful in reducing symptoms, the role of acid suppression therapy to reduce esophageal reflux, is still uncertain.[1]

Medical therapy for nutcracker esophagus includes the use of calcium-channel blockers, which relax the LES and palliate the dysphagia symptoms. Diltiazem has been used in randomized control studies with good effect.[2] Nitrate medications, including isosorbide dinitrate, given before meals may also help relax the LES and improve symptoms.[3] Phosphodiesterase inhibitors, such as sildenafil have also been tried in case series for treatment.[3] Finally, trazodone, an anti-depressant that reduces visceral sensitivity, has also been shown to reduce chest pain symptoms in patients with nutcracker esophagus.[3][4][5]

Endoscopic therapy with botulinum toxin, known also as Botox, can also be used to temporarily improve symptoms,[6] but the effect is temporarily and may only last for weeks.

References

  1. Borjesson M, Rolny P, Mannheimer C, Pilhall M (2003). "Nutcracker oesophagus: a double-blind, placebo-controlled, cross-over study of the effects of lansoprazole". Aliment Pharmacol Ther. 18 (11–12): 1129–35. PMID 14653833.
  2. Cattau E, Castell D, Johnson D, Spurling T, Hirszel R, Chobanian S, Richter J (1991). "Diltiazem therapy for symptoms associated with nutcracker esophagus". Am J Gastroenterol. 86 (3): 272–6. PMID 1998307.
  3. 3.0 3.1 3.2 Tutuian R, Castell D (2006). "Esophageal motility disorders (distal esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter): modern management". Curr Treat Options Gastroenterol. 9 (4): 283–94. PMID 16836947.
  4. Achem S, Kolts B (1992). "Current medical therapy for esophageal motility disorders". Am J Med. 92 (5A): 98S–105S. PMID 1595773.
  5. Kahrilas P (2000). "Esophageal motility disorders: current concepts of pathogenesis and treatment". Can J Gastroenterol. 14 (3): 221–31. PMID 10758419.
  6. Tutuian R, Castell D (2006). "Esophageal motility disorders (distal esophageal spasm, nutcracker esophagus, and hypertensive lower esophageal sphincter): modern management". Curr Treat Options Gastroenterol. 9 (4): 283–94. PMID 16836947.

Template:WH Template:WS